Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that the ARROW® EZ-IO® Vascular Access System has reached a new growth milestone by surpassing 3 million needles sold globally in early September 2014.

“This is a significant milestone for the Arrow® EZ-IO® Vascular Access System because it demonstrates that IO is gaining acceptance for emergency and difficult vascular access,” said Jay White, President and General Manager, Vascular Access Division, Teleflex. “It demonstrates the lifesaving capabilities of the EZ-IO vascular Access System through its clinical benefits centered around ease of use, speed to vascular access, and safety.”

The Arrow® EZ-IO® Vascular Access System is a safe, fast, effective vascular access option that provides peripheral venous access with central venous catheter performance. It’s ideal for patients in whom peripheral vascular access is difficult or impossible in the hospital and pre-hospital setting.

In a recent Huffington Post article profiling Dr. Suzanne Donovan, a physician traveling to Sierra Leone to fight the recent Ebola outbreak, intraosseous (IO) infusion was identified as one of the safest ways of providing fluids to patients who can't take oral fluids. Teleflex is proud to have supported Dr. Donovan’s efforts with a donation.

Teleflex will feature the ARROW® EZ-IO® Vascular Access System at the upcoming annual conferences for the American College of Emergency Physicians (ACEP) and EMS World Expo. Both conferences will feature educational cadaver labs that will provide a unique hands-on opportunity for participants to practice vascular access techniques as well as receive an in-depth review of associated anatomy on cadaveric specimens.

ACEP 2014 will be held October 27-30 at the McCormick Convention Center, in Chicago, IL. EMS World Expo will be held November 9-13 at the Music City Center, in Nashville, TN.

Potential complications with the ARROW® EZ-IO® Vascular Access System may include local or systemic infection, hematoma, extravasations, or any other complications associated with percutaneous insertion of sterile devices.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Wayne, PA, Teleflex employs approximately 11,500 people worldwide and serves healthcare providers in more than 150 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements.

These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

References:

http://www.huffingtonpost.com/claire-fordham/into-africa-to-fight-ebol_b_5759636.html

Teleflex, Arrow, and EZ-IO are trademarks of Teleflex Incorporated and its affiliates.

© 2014 Teleflex Incorporated. All rights reserved. MC-000738

Teleflex IncorporatedJake ElguiczeTreasurer and Vice President, Investor Relations610-948-2836jake.elguicze@teleflex.comwww.teleflex.com

Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Teleflex Charts.
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Teleflex Charts.